This page lists the SEC filings reported by HHLR ADVISORS, LTD..
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2019-02-14 | Hillhouse Capital Advisors, Ltd. | China Biologic Products Holdings, Inc. | 2,751,200 | 7.0% | EDGAR |
SC 13G/A | 2019-02-14 | Hillhouse Capital Advisors, Ltd. | Bright Scholar Education Holdings Ltd | 3,985,797 | 16.7% | EDGAR |
SC 13G/A | 2019-02-14 | Hillhouse Capital Advisors, Ltd. | Apellis Pharmaceuticals, Inc. | 2,229,708 | 4.0% | EDGAR |
SC 13G | 2019-02-14 | Hillhouse Capital Advisors, Ltd. | Kiniksa Pharmaceuticals, Ltd. | 1,388,888 | 8.8% | EDGAR |
SC 13G | 2019-01-10 | Hillhouse Capital Advisors, Ltd. | MOGU Inc. | 130,587,127 | 5.5% | EDGAR |
SC 13D/A | 2019-01-03 | Hillhouse Capital Advisors, Ltd. | BeiGene, Ltd. | 63,117,389 | 8.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.